Anthony MD - Apollo Endosurgery CoFounder Partner

Insider

Anthony MD is CoFounder Partner of Apollo Endosurgery
Phone512 279-5100
Webwww.apolloendo.com

Apollo Endosurgery Management Efficiency

The company has return on total asset (ROA) of (0.1439) % which means that it has lost $0.1439 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8492) %, meaning that it created substantial loss on money invested by shareholders. Apollo Endosurgery's management efficiency ratios could be used to measure how well Apollo Endosurgery manages its routine affairs as well as how well it operates its assets and liabilities.
Apollo Endosurgery currently holds 33.96 M in liabilities with Debt to Equity (D/E) ratio of 1.16, which is about average as compared to similar companies. Apollo Endosurgery has a current ratio of 6.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Apollo Endosurgery's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Rochelle ManeyArtivion
45
Daniel BevevinoArtivion
61
Peter MDInvivyd
N/A
David MBAInvivyd
48
Marshall StantonArtivion
64
Joshua WellsArtivion
N/A
Laura WalkerInvivyd
39
Kyra FairclothInvivyd
N/A
Andrew GreenArtivion
52
Marna BorgstromArtivion
67
Dennis MaierArtivion
50
John DavisArtivion
61
Jean HollowayArtivion
63
Frederick DriscollInvivyd
73
Matthew GetzArtivion
57
Amy HortonArtivion
50
Elham PharmDInvivyd
54
MSc MDInvivyd
N/A
Scott CappsArtivion
53
Thomas AckermanArtivion
66
Rebecca DaboraInvivyd
65
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas. Apollo Endosurgery operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 202 people. Apollo Endosurgery (APEN) is traded on NASDAQ Exchange in USA and employs 22 people.

Management Performance

Apollo Endosurgery Leadership Team

Elected by the shareholders, the Apollo Endosurgery's board of directors comprises two types of representatives: Apollo Endosurgery inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apollo. The board's role is to monitor Apollo Endosurgery's management team and ensure that shareholders' interests are well served. Apollo Endosurgery's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apollo Endosurgery's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeffrey Black, S CFO
Robert MD, CoFounder Partner
Peter MD, CoFounder Partner
Charles McKhann, Pres CEO
Anthony MD, CoFounder Partner
John Molesphini, Ex Operations
Christopher MD, CoFounder Officer
Sydney MD, CoFounder Partner
Sergey MD, CoFounder Partner
FACP MD, CoFounder

Apollo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apollo Endosurgery a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Apollo Endosurgery

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apollo Endosurgery position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollo Endosurgery will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Hershey could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hershey when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hershey - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hershey Co to buy it.
The correlation of Hershey is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hershey moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hershey moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hershey can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Apollo Stock

If you are still planning to invest in Apollo Endosurgery check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apollo Endosurgery's history and understand the potential risks before investing.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments